← Back to Search

Treatment for Diabetic Macular Edema

N/A
Waitlist Available
Led By Michael J Elman, MD
Research Sponsored by Elman Retina Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day (patients only seen once for assessments)
Awards & highlights

Summary

This trial will assess the incidence of new and/or undiagnosed diabetic macular edema (DME) in diabetic patients that undergo a DME screening exam. The screening exam will consist of medical history, Electronic ETDRS visual acuity assessment, SD-OCT and color fundus photography

Eligible Conditions
  • Diabetic Macular Edema

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day (patients only seen once for assessments)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day (patients only seen once for assessments) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Assess the incidence of new and/or undiagnosed diabetic macular edema.
Secondary study objectives
Streamlining and identification of patients at risk of diabetic macular edema

Find a Location

Who is running the clinical trial?

Elman Retina GroupLead Sponsor
3 Previous Clinical Trials
393 Total Patients Enrolled
Genentech, Inc.Industry Sponsor
1,550 Previous Clinical Trials
567,864 Total Patients Enrolled
Michael J Elman, MDPrincipal InvestigatorElman Retina Group, P.A.
~55 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top